Publications and communications of Yves Henrotin

Raman, R., Bahri, M. A., Degueldre, C., Caetano da Silva, C., Sanchez, C., Ostertag, A., Collet, C., Cohen-Solal, M., Plenevaux, A., Henrotin, Y., & Muller, M. (14 January 2024). A Zebrafish Mutant in the Extracellular Matrix Protein Gene efemp1 as a Model for Spinal Osteoarthritis. Animals, 14 (1), 74. doi:10.3390/ani14010074

Henrotin, Y., Herman, J., Uebelhoer, M., Wauquier, F., Boutin-Wittrant, L., Donneau, A.-F., Monseur, J., Fotso, V. M., Duquenne, M., Wagner, M., Bouvret, E., Costes, B., & Wittrant, Y. (21 September 2023). Oral supplementation with fish cartilage hydrolysate in an adult population suffering from knee pain and function discomfort: results from an innovative approach combining an exploratory clinical study and an ex vivo clinical investigation. BMC Musculoskeletal Disorders, 24 (1), 748. doi:10.1186/s12891-023-06800-4

Zappia, J., Tong, Q., Van der Cruyssen, R., Cornelis, F. M. F., Lambert, C., Pinto Coelho, T., Grisart, J., Kague, E., Lories, R. J., Muller, M., Elewaut, D., Hammond, C. L., Sanchez, C., & Henrotin, Y. (20 September 2023). Osteomodulin downregulation is associated with osteoarthritis development. Bone Research, 11 (1), 49. doi:10.1038/s41413-023-00286-5

Gérain, J., Uebelhoer, M., Costes, B., Herman, J., Pietri, S., Donneau, A.-F., Monseur, J., & Henrotin, Y. (22 June 2023). NASAFYTOL® supplementation in adults hospitalized with COVID-19 infection: results from an exploratory open-label randomized controlled trial. Frontiers in Nutrition, 10. doi:10.3389/fnut.2023.1137407

Henrotin, Y., Szekanecz, Z., & Masuko, K. (2023). Editorial: Reviews in rheumatology. Frontiers in Medicine, 10, 1153419. doi:10.3389/fmed.2023.1153419

Im, G.-I., & Henrotin, Y. (2023). Regenerative medicine for early osteoarthritis. Therapeutic Advances in Musculoskeletal Disease, 15, 1759720X231194813. doi:10.1177/1759720X231194813

Uebelhoer, M., Lambert, C., Grisart, J., Guse, K., Plutizki, S., & Henrotin, Y. (2023). Interleukins, growth factors, and transcription factors are key targets for gene therapy in osteoarthritis: A scoping review. Frontiers in Medicine, 10, 1148623. doi:10.3389/fmed.2023.1148623

Conrozier, T., Diraçoglù, D., Monfort, J., Chevalier, X., Bard, H., Baron, D., Jerosch, J., Migliore, A., Richette, P., & Henrotin, Y. (2022). EUROVISCO Good Practice Recommendations for a First Viscosupplementation in Patients with Knee Osteoarthritis. Cartilage, 19476035221138958. doi:10.1177/19476035221138958

Holden, M. A., Metcalf, B., Lawford, B. J., Hinman, R. S., Boyd, M., Button, K., Collins, N. J., Cottrell, E., Henrotin, Y., Larsen, J. B., Master, H., Skou, S. T., Thoma, L. M., Rydz, R., Wellsandt, E., White, D. K., & Bennell, K. (2022). Recommendations for the delivery of therapeutic exercise for people with knee and/or hip osteoarthritis. An international consensus study from the OARSI Rehabilitation Discussion Group. Osteoarthritis and Cartilage. doi:10.1016/j.joca.2022.10.009

Henrotin, Y., Michlmayr, C., Rau, S. M., Quirke, A.-M., Bigoni, M., & Ueberall, M. A. (October 2022). Combination of Enzymes and Rutin to Manage Osteoarthritis Symptoms: Lessons from a Narrative Review of the Literature. Rheumatology and Therapy, 9 (5), 1305 - 1327. doi:10.1007/s40744-022-00472-7

Sanchez, C., Zappia, J., Lambert, C., FOGUENNE, J., Dierckxsens, Y., Dubuc, J.-E., Delcour, J.-P., Gothot, A., & Henrotin, Y. (11 August 2022). Curcuma longa and Boswellia serrata Extracts Modulate Different and Complementary Pathways on Human Chondrocytes In Vitro: Deciphering of a Transcriptomic Study. Frontiers in Pharmacology, 13. doi:10.3389/fphar.2022.931914

Henrotin, Y., Cozannet, R. L., Fança-Berthon, P., Truillet, R., Cohen-Solhal, M., DunnGalvin, G., Grouin, J.-M., & Doolan, A. (07 July 2022). Rubus idaeus extract improves symptoms in knee osteoarthritis patients: results from a phase II double-blind randomized controlled trial. BMC Musculoskeletal Disorders, 23 (1), 650. doi:10.1186/s12891-022-05612-2

Angelini, F., Widera, P., Mobasheri, A., Blair, J., Struglics, A., Uebelhoer, M., Henrotin, Y., Marijnissen, A. C., Kloppenburg, M., Blanco, F. J., Haugen, I. K., Berenbaum, F., Ladel, C., Larkin, J., Bay-Jensen, A. C., & Bacardit, J. (2022). Osteoarthritis endotype discovery via clustering of biochemical marker data. Annals of the Rheumatic Diseases, 81 (5), 666-675. doi:10.1136/annrheumdis-2021-221763

Henrotin, Y. (2022). Osteoarthritis in year 2021: biochemical markers. Osteoarthritis and Cartilage, 30 (2), 237-248. doi:10.1016/j.joca.2021.11.001

Horcajada, M.-N., Beaumont, M., Sauvageot, N., Poquet, L., Saboundjian, M., Costes, B., Verdonk, P., Brands, G., Brasseur, J., Urbin-Choffray, D., Vandenberghe, M., Brabants, K., De Vlam, K., Fache, W., Jandrain, B., Grek, V., MALAISE, M., & Henrotin, Y. (2022). An oleuropein-based dietary supplement may improve joint functional capacity in older people with high knee joint pain: findings from a multicentre-RCT and post hoc analysis. Therapeutic Advances in Musculoskeletal Disease, 14, 1759720X211070205. doi:10.1177/1759720X211070205

Sanchez, C., Lambert, C., Dubuc, J.-E., Bertrand, J., Pap, T., & Henrotin, Y. (20 December 2021). Syndecan-4 is Increased in Osteoarthritic Knee, but not Hip or Shoulder, Articular Hypertrophic Chondrocytes. Cartilage, 13 (Issue 2_suppl), 862S-871. doi:10.1177/1947603519870855

Sanchez, C., Hemmer, K., Krömmelbein, N., Seilheimer, B., Dubuc, J.-E., Antoine, C., & Henrotin, Y. (11 May 2021). Reduction of Matrix Metallopeptidase 13 and Promotion of Chondrogenesis by Zeel T in Primary Human Osteoarthritic Chondrocytes. Frontiers in Pharmacology, 12, 1-12. doi:10.3389/fphar.2021.635034

Conrozier, T., Raman, R., Chevalier, X., Henrotin, Y., Monfort, J., Diraçoglù, D., Bard, H., Baron, D., Jerosch, J., Richette, P., & Migliore, A. (2021). Viscosupplementation for the treatment of osteoarthritis. The contribution of EUROVISCO group. Therapeutic Advances in Musculoskeletal Disease, 13. doi:10.1177/1759720X211018605

Henrotin, Y., Antoine, C., Zwerts, E., Neutelings, T., & Bouvret, E. (2021). Oral supplementation with fish cartilage hydrolysate accelerates joint function recovery in rat model of traumatic knee osteoarthritis. Food Science and Nutrition, 9 (6), 2877-2885. doi:10.1002/fsn3.2244

Holden, M. A., Button, K., Collins, N. J., Henrotin, Y., Hinman, R. S., Larsen, J. B., Metcalf, B., Master, H., Skou, S. T., Thoma, L. M., Wellsandt, E., White, D. K., & Bennell, K. (2021). Guidance for Implementing Best Practice Therapeutic Exercise for Patients With Knee and Hip Osteoarthritis: What Does the Current Evidence Base Tell Us? Arthritis Care and Research, 73 (12), 1746-1753. doi:10.1002/acr.24434

L'Hote, C., Cordier, B., Labasse, A., Boileau, C., Costes, B., & Henrotin, Y. (2021). Identification of new biomarkers for sarcopenia and characterization of cathepsin D biomarker. JCSM Rapid Communications, 4, 122-132. doi:10.1002/rco2.26

Lambert, C., Bellemère, G., Boyer, G., Ponelle, F., Bauer, T., Legeny, M.-C., Baudouin, C., & Henrotin, Y. (2021). Composition Analysis and Pharmacological Activity of Avocado/Soybean Unsaponifiable Products Used in the Treatment of Osteoarthritis. Frontiers in Pharmacology, 12, 781389. doi:10.3389/fphar.2021.781389

Lambert, C., Zappia, J., Sanchez, C., Florin, A., Dubuc, J.-E., & Henrotin, Y. (2021). The Damage-Associated Molecular Patterns (DAMPs) as Potential Targets to Treat Osteoarthritis: Perspectives From a Review of the Literature. Frontiers in Medicine, 7, 607186. doi:10.3389/fmed.2020.607186

Mobasheri, A., Fonseca, J. E., Gualillo, O., Henrotin, Y., Largo, R., Herrero-Beaumont, G., & Rocha, F. A. C. (2021). Editorial: Inflammation and Biomarkers in Osteoarthritis. Frontiers in Medicine, 8, 727700. doi:10.3389/fmed.2021.727700

Florin, A., Lambert, C., Sanchez, C., Zappia, J., Durieux, N., Tieppo, A. M., Mobasheri, A., & Henrotin, Y. (2020). The secretome of skeletal muscle cells: A systematic review. Osteoarthritis and Cartilage Open. doi:10.1016/j.ocarto.2019.100019

Batshon, G., Elayyan, J., Qiq, O., Reich, E., Ben-Aderet, L., Kandel, L., Haze, A., Steinmeyer, J., Lefebvre, V., Zhang, H., Elisseeff, J., Henrotin, Y., Mobasheri, A., & Dvir-Ginzberg, M. (2020). Serum NT/CT SIRT1 ratio reflects early osteoarthritis and chondrosenescence. Annals of the Rheumatic Diseases, 79 (10), 1370-1380. doi:10.1136/annrheumdis-2020-217072

Montjean, R., Escaich, S., Paolini, R., Carelli, C., Pirson, S., Neutelings, T., Henrotin, Y., & Vêtu, C. (2020). REG-O3 chimeric peptide combining growth hormone and somatostatin sequences improves joint function and prevents cartilage degradation in rat model of traumatic knee osteoarthritis. PLoS ONE, 15 (4), 0231240. doi:10.1371/journal.pone.0231240

Zappia, J., Joiret, M., Sanchez, C., Lambert, C., Geris, L., Muller, M., & Henrotin, Y. (2020). From translation to protein degradation as mechanisms for regulating biological functions: A review on the SLRP family in skeletal tissues. Biomolecules, 10, 80. doi:10.3390/biom10010080

Henrotin, Y. (February 2019). Les nouveaux biomarqueurs de l'arthrose. Lettre du Rhumatologue, 449, 16-19.

Boisson, M., Borderie, D., Henrotin, Y., Teboul-Coré, S., Lefèvre-Colau, M.-M., Rannou, F., & Nguyen, C. (2019). Serum biomarkers in people with chronic low back pain and Modic 1 changes: a case-control study. Scientific Reports, 9 (1). doi:10.1038/s41598-019-46508-x

de Visser, H. M., Sanchez, C., Mastbergen, S. C., Lafeber, F. P. J. G., Henrotin, Y., & Weinans, H. (2019). Fib3-3 as a Biomarker for Osteoarthritis in a Rat Model with Metabolic Dysregulation. Cartilage, 10 (3), 329-334. doi:10.1177/1947603518754629

Elango, J., Saravanakumar, K., Rahman, S. U., Henrotin, Y., Regenstein, J. M., Wu, W., & Bao, B. (2019). Chitosan-collagen 3d matrix mimics trabecular bone and regulates rankl-mediated paracrine cues of differentiated osteoblast and mesenchymal stem cells for bone marrow macrophage-derived osteoclastogenesis. Biomolecules, 9 (5). doi:10.3390/biom9050173

Henrotin, Y., Bannuru, R., Malaise, M., Ea, H.-K., Confavreux, C., Bentin, J., Urbin-Choffray, D., Conrozier, T., Brasseur, J.-P., Thomas, P., Hick, A.-C., Marinello, A., Giordan, N., & Richette, P. (2019). Hyaluronan derivative HYMOVIS® increases cartilage volume and type ii collagen turnover in osteoarhritic knee: Data from MOKHA study. BMC Musculoskeletal Disorders, 20 (1). doi:10.1186/s12891-019-2667-0

Henrotin, Y., Malaise, M., Wittoek, R., De Vlam, K., Brasseur, J.-P., Luyten, F. P., Jiangang, Q., Van Den Berghe, M., Uhoda, R., Bentin, J., De Vroey, T., Erpicum, L., Donneau, A.-F., & Dierckxsens, Y. (2019). Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: A double-blind multicenter randomized placebo controlled three-arm study. Arthritis Research and Therapy, 21 (1). doi:10.1186/s13075-019-1960-5

Legrand, C., Ahmed, U., Anwar, A., Rajpoot, K., Pasha, S., Lambert, C., Davidson, R. K., Clark, I. M., Thornalley, P. J., Henrotin, Y., & Rabbani, N. (June 2018). Glycation marker glucosepane increases with the progression of osteoarthritis and correlates with morphological and functional changes of cartilage in vivo. Arthritis Research and Therapy, 20 (1), 131. doi:10.1186/s13075-018-1636-6

Elango, J., Lee, J., Wang, S., Henrotin, Y., De Val, J. E. M. S., Regenstein, J. M., Lim, S. Y., Bao, B., & Wu, W. (2018). Evaluation of differentiated bone cells proliferation by blue shark skin collagen via biochemical for bone tissue engineering. Marine Drugs, 16 (10), 350. doi:10.3390/md16100350

Elango, J., Sanchez, C., de Val, J. E. M. S., Henrotin, Y., Wang, S., Motaung, K. S. C. M., Guo, R., Wang, C., Robinson, J., Regenstein, J. M., Bao, B., & Wu, W. (2018). Cross-talk between primary osteocytes and bone marrow macrophages for osteoclastogenesis upon collagen treatment. Scientific Reports, 8 (1), 5318. doi:10.1038/s41598-018-23532-x

Henrotin, Y. (2018). Avocado/Soybean Unsaponifiables (Piacledine®300) show beneficial effect on the metabolism of osteoarthritic cartilage, synovium and subchondral bone: An overview of the mechanisms. AIMS Medical Science, 5 (1), 33-52.

Sanchez, C., Mazzucchelli, G., Lambert, C., Comblain, F., De Pauw, E., & Henrotin, Y. (2018). Comparison of secretome from osteoblasts derived from sclerotic versus non-sclerotic subchondral bone in OA: A pilot study. PLoS ONE, 13 (3), 0194591. doi:10.1371/journal.pone.0194591

Sanchez, C., Bay-Jensen, A.-C., Pap, T., Dvir-Ginzberg, M., Quasnichka, H., Barrett-Jolley, R., Mobasheri, A., & Henrotin, Y. (August 2017). Chondrocyte secretome: a source of novel insights and exploratory biomarkers of osteoarthritis. Osteoarthritis and Cartilage, 25, 1199-1209. doi:10.1016/j.joca.2017.02.797

Demoulin, C., Depas, Y., Vanderthommen, M., Henrotin, Y., Wolfs, S., Cagnie, B., & Hidalgo, B. (March 2017). LA THÉRAPIE MANUELLE ORTHOPÉDIQUE : définition, caractéristiques et mise au point sur la situation en Belgique. Revue Médicale de Liège, 72 (3), 126-131.

Bartels, E. M., Henrotin, Y., Bliddal, H., Centonze, P., & Henriksen, M. (2017). Relationship between weight loss in obese knee osteoarthritis patients and serum biomarkers of cartilage breakdown: secondary analyses of a randomised trial. Osteoarthritis and Cartilage, 25 (10), 1641-1646. doi:10.1016/j.joca.2017.06.009

Comblain, F., Barthelemy, N., Lefebvre, M., Schwartz, C., Lesponne, I., Serisier, S., Feugier, A., Balligand, M., & Henrotin, Y. (2017). A randomized, double-blind, prospective, placebo-controlled study of the efficacy of a diet supplemented with curcuminoids extract, hydrolyzed collagen and green tea extract in owner's dogs with osteoarthritis. BMC Veterinary Research, 13, 395. doi:10.1186/s12917-017-1317-8

Henrotin, Y., Berenbaum, F., Chevalier, X., Marty, M., Richette, P., & Rannou, F. (2017). Reduction of the Serum Levels of a Specific Biomarker of Cartilage Degradation (Coll2-1) by Hyaluronic Acid (KARTILAGE® CROSS) Compared to Placebo in Painful Knee Osteoarthritis Patients: The EPIKART Study, a Pilot Prospective Comparative Randomized Double Blind Trial. BMC Musculoskeletal Disorders, 18 (1). doi:10.1186/s12891-017-1585-2

Lazzarini, N., Runhaar, J., Bay-Jensen, A. C., Thudium, C. S., Bierma-Zeinstra, S. M. A., Henrotin, Y., & Bacardit, J. (2017). A machine learning approach for the identification of new biomarkers for knee osteoarthritis development in overweight and obese women. Osteoarthritis and Cartilage, 25 (12), 2014-2021. doi:10.1016/j.joca.2017.09.001

Luo, Y., Sinkeviciute, D., He, Y., Karsdal, M., Henrotin, Y., Mobasheri, A., Önnerfjord, P., & Bay-Jensen, A. (2017). The minor collagens in articular cartilage. Protein and Cell, 8 (8), 560-572. doi:10.1007/s13238-017-0377-7

Comblain, F., Dubuc, J.-E., Lambert, C., Sanchez, C., Lesponne, I., Serisier, S., & Henrotin, Y. (2016). Identification of Targets of a New Nutritional Mixture for Osteoarthritis Management Composed by Curcuminoids Extract, Hydrolyzed Collagen and Green Tea Extract. PLoS ONE. doi:10.1371/journal.pone.0156902

Henrotin, Y., Sanchez, C., Bay-Jensen, A. C., & Mobasheri, A. (June 2016). Osteoarthritis biomarkers derived from cartilage extracellular matrix: Current status and future perspectives. Annals of Physical and Rehabilitation Medicine, 59 (3), 145-148. doi:10.1016/j.rehab.2016.03.004

Runhaar, J.* , Sanchez, C.* , Taralla, S., Henrotin, Y., & Bierma-Zeinstra, S. M. A. (April 2016). Fibulin-3 fragments are prognostic biomarkers of osteoarthritis incidence in overweight and obese women. Osteoarthritis and Cartilage, 24 (4), 672-678. doi:10.1016/j.joca.2015.10.013

Bay-Jensen, A.-C., Henrotin, Y., Karsdal, M., & Mobasheri, A. (2016). The need for predictive, prognostic, objective and complementary blood-based biomarkers in osteoarthritis (OA). EBioMedicine. doi:10.1016/j.ebiom.2016.05.004

Bay-Jensen, A. C., Reker, D., Kjelgaard-Petersen, C. F., Mobasheri, A., Karsdal, M. A., Ladel, C., Henrotin, Y., & Thudium, C. S. (2016). Osteoarthritis year in review 2015: soluble biomarkers and the BIPED criteria. Osteoarthritis and Cartilage, 24 (1), 9-20. doi:10.1016/j.joca.2015.10.014

Hochberg, M. C., Martel-Pelletier, J., Monfort, J., Moller, I., Castillo, J. R., Arden, N., Berenbaum, F., Blanco, F. J., Conaghan, P. G., Domenech, G., Henrotin, Y., Pap, T., Richette, P., Sawitzke, A., du Souich, P., Pelletier, J. P., & Group, M. I. (2016). Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib. Annals of the Rheumatic Diseases, 75 (1), 37-44. doi:10.1136/annrheumdis-2014-206792

Moller, I., Gharbi, M., Martinez Serrano, H., Herrero Barbero, M., Verges Milano, J., & Henrotin, Y. (2016). Effect of chondroitin sulfate on soluble biomarkers of osteoarthritis: a method to analyze and interpret the results from an open-label trial in unilateral knee osteoarthritis patients. BMC Musculoskeletal Disorders, 17 (1), 416. doi:10.1186/s12891-016-1268-4

Oprenyeszk, F., Sanchez, C., Dubuc, J.-E., Maquet, V., Henrist, C., Compère, P., & Henrotin, Y. (28 May 2015). Chitosan enriched three-dimensional matrix reduces inflammatory and catabolic mediators production by human chondrocytes. PLoS ONE, 10 (5). doi:10.1371/journal.pone.0128362

Comblain, F., Sanchez, C., Lesponne, I., Balligand, M., Serisier, S., & Henrotin, Y. (2015). Curcuminoids Extract, Hydrolyzed Collagen and Green Tea Extract Synergically Inhibit Inflammatory and Catabolic Mediator's Synthesis by Normal Bovine and Osteoarthritic Human Chondrocytes in Monolayer. PLoS ONE. doi:10.1371/journal.pone.0121654

Horcajada, M.-N.* , Sanchez, C.* , Membrez Scalfo, Drion, P., Comblain, F., Taralla, S., Donneau, A.-F., Offord, E. A., & Henrotin, Y. (2015). Oleuropein or rutin consumption decreases the spontaneous development of osteoarthritis in the Hartley guinea pig. Osteoarthritis and Cartilage, 23 (1), 94-102. doi:10.1016/j.joca.2014.08.016

Mobasheri, A., & Henrotin, Y. (2015). Biomarkers of (osteo)arthritis. Biomarkers: Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals, 20 (8), 513-8. doi:10.3109/1354750X.2016.1140930

Richette, P., Chevalier, X., Ea, H. K., Eymard, F., Henrotin, Y., Ornetti, P., Sellam, J., Cucherat, M., & Marty, M. (2015). Hyaluronan for knee osteoarthritis: an updated meta-analysis of trials with low risk of bias. RMD Open, 1 (1), 000071. doi:10.1136/rmdopen-2015-000071

Sanchez, C., Horcajada, M.-N., Membrez Scalfo, F., Ameye, L., Offord, E., & Henrotin, Y. (2015). Carnosol Inhibits Pro-Inflammatory and Catabolic Mediators of Cartilage Breakdown in Human Osteoarthritic Chondrocytes and Mediates Cross-Talk between Subchondral Bone Osteoblasts and Chondrocytes. PLoS ONE, 10 (8), 0136118. doi:10.1371/journal.pone.0136118

McAlindon, T. E., & Henrotin, Y. (March 2014). OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis and Cartilage, 22 (3), 363-388. doi:10.1016/j.joca.2014.01.003

Henrotin, Y. (2014). Does signalling pathways inhibition hold therapeutic promise for osteoarthritis? Joint Bone Spine, 81, 281-283. doi:10.1016/j.jbspin.2014.03.002

Henrotin, Y. (2014). Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial. BMC Complementary and Alternative Medicine. doi:10.1186/1472-6882-14-159

Henrotin, Y., Marty, M., & Mobasheri, A. (2014). What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis? Maturitas, 78, 184-187. doi:10.1016/j.maturitas.2014.04.015

Dobson, F., & Henrotin, Y. (October 2013). OARSI recommended performance-based tests to assess clinical function in osteoathritis of hip and knee: author's reply. Osteoarthritis and Cartilage, 21 (10), 1625-1626.

Henrotin, Y., Labasse, A., Franck, T., Bosseloir, A., Bury, T., & DEBERG, M. (2013). Collagen catabolism through Coll2-1 and Coll2-1NO and myeloperoxidase activity in marathon runners. SpringerPlus, 2 (1), 92. doi:10.1186/2193-1801-2-92

Lambert, C., Mathy-Hartert, M., Dubuc, J., Montell, E., Vergés, J., Munaut, C., Noël, A., & Henrotin, Y. (March 2012). Characterization of synovial angiogenesis in osteoarthritis patients and its modulation by chondroitin sulfate. Arthritis Research and Therapy, 14 (2), 58. doi:10.1186/ar3771

Henrotin, Y. (2011). Muscle: a source of progenitor cells for bone fracture healing. BMC Medicine, 9, 136. doi:10.1186/1741-7015-9-136

Mathy, C., Broonen, J.-P., Henrotin, Y., Marty, M., Legout, V., Genevay, S., Duplan, B., Bazin, T., Laroche, F., Savarieau, B., & Cedraschi, C. (2011). Development and validation of a questionnaire assessing volitional competencies to enhance the performance of physical activities in chronic low back pain patients. BMC Musculoskeletal Disorders, 12, 111. doi:10.1186/1471-2474-12-111

Henrotin, Y., & Chevalier, X. (2010). Recommandations sur la prise en charge de l'arthrose de la hanche et du genou. Pour qui ? Pourquoi ? Pour quoi faire ? Presse Médicale. doi:10.1016/j.lpm.2010.03.029

Lejeune, J.-P., Serteyn, D., Gangl, M., Schneider, N., Deby-Dupont, G., Deberg, M., & Henrotin, Y. (July 2007). Plasma concentrations of a type II collagen-derived peptide and its nitrated form in growing ardenner sound horses and in horses suffering from juvenile digital degenerative osteoarthropathy. Veterinary Research Communications, 31 (5), 591-601. doi:10.1007/s11259-007-3518-2

Gangl, M., Deberg, M., Lejeune, J.-P., Schneider, N., Grulke, S., Peters, F., Vila, T., Deby-Dupont, G., Serteyn, D., & Henrotin, Y. (2007). A type II-collagen derived peptide and its nitrated form as new markers of inflammation and cartilage degradation in equine osteochondral lesions. Research in Veterinary Science, 82, 68-75. doi:10.1016/j.rvsc.2006.03.008

Demoulin, C., Fauconnier, C., Vanderthommen, M., & Henrotin, Y. (2005). Recommandations pour l'elaboration d'un bilan fonctionnel de base du patient lombalgique. Revue Médicale de Liège, 60 (7-8, Jul-Aug), 661-8.

Bruyère, O., Henrotin, Y., Honore, A., Rovati, L. C., Seidel, L., Dardenne, C.-B., & Reginster, J.-Y. (April 2003). Impact of the joint space width measurement method on the design of knee osteoarthritis studies. Aging Clinical and Experimental Research, 15 (2), 136-41. doi:10.1007/BF03324491

Reginster, J.-Y., Paul, I., & Henrotin, Y. (July 2001). Comment positionner l'acéclofénac au sein de l'arsenal thérapeutique des pathologies ostéo-articulaires chroniques ? Revue Médicale de Liège, 56 (7), 484-8.

Henrotin, Y., Deby-Dupont, G., & Reginster, J.-Y. (June 2001). Les mediateurs biochimiques de l'inflammation. Revue Médicale de Liège, 56 (6), 433-42.

Reginster, J.-Y., & Henrotin, Y. (March 2001). Pharma clinics. Comment je traite.... L'arthrose. 2eme partie: Nouvelles perspectives therapeutiques. Revue Médicale de Liège, 56 (3), 135-9.

Reginster, J.-Y., & Henrotin, Y. (February 2001). Pharma clinics. Comment je traite.... L'arthrose. 1ère partie: Rappel physiopathologique et traitement symptomatique. Revue Médicale de Liège, 56 (2), 63-7.

Reginster, J.-Y., Henrotin, Y., Christiansen, C., Gamwell-Henriksen, E., Bruyère, O., Collette, J., & Christgau, S. (2001). Bone resorption in post-menopausal women with normal and low BMD assessed with biochemical markers specific for telopeptide derived degradation products of collagen type I. Calcified Tissue International, 69 (3), 130-137. doi:10.1007/s002230020042

Henrotin, Y., Sanchez, C., De Pauw, E., & Mazzucchelli, G. (30 January 2019). OSTEOMODULIN AND OSTEOMODULIN FRAGMENTS AS BIOMARKERS FOR OSTEOARTHRITIS AND USE THEREOF.

Henrotin, Y., Sanchez, C., De Pauw, E., & Mazzucchelli, G. (27 September 2017). Osteomodulin and osteomodulin fragments as biomarkers for osteoarthritis and use thereof.

Henrotin, Y., Sanchez, C., De Pauw, E., & Mazzucchelli, G. (25 September 2017). Osteomodulin and osteomodulin fragments as biomarkers for osteoarthritis and use thereof.

Henrotin, Y., Lambert, C., Borderie, D., & Rannou, F. (23 June 2016). Coll2-1 peptide and its nitrated form as therapeutic targets for osteoarthritis treatment.

Henrotin, Y., Gharbi, M., DEBERG, M., & De Pauw, E. (20 January 2016). Biomarker for osteoarthritis and use thereof.

Henrotin, Y., Sanchez, C., Oprenyeszk, F., & Drion, P. (18 November 2014). Intra-articularly supplementation method for treating joint diseases and injuries.

Henrotin, Y., Kesteloot, F., & Sanchez, C. (11 November 2014). Cell cultivation in chitosan alginate hydrogel beads.

Henrotin, Y., Sanchez, C., Oprenyeszk, F., & Drion, P. (02 January 2013). An intra-articular supplement for use in treating joint diseases and injuries.

Henrotin, Y. (04 December 2015). Les marqueurs biologiques de l'arthrose : de la découverte à l'industrialisation [Paper presentation]. Université de Nantes, Nantes, France.

Henrotin, Y. (2019). Glucosamine et chondroitine: un intérêt majeur pour les articulations. In Les cahiers des compléments alimentaires - l'intégral (pp. 69-70). Paris, France: Synadiet.

Henrotin, Y. (2019). Glucosamine et chondroïtine : à titre préventif pour diminuer les coûts liés à l’arthrose. In Les cahiers des compléments alimentaires - l'abrégé (pp. 6-7). Paris, France: Synadiet.

Henrotin, Y. (2016). Les marqueurs biologiques de l'arthrose : de la conception à la qualification. In Institut Servier, De l'arthrose aux arthroses (pp. 58-67). Paris, France: Springer.